rs1060501722
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001032221.6(STXBP1):c.1434G>A(p.Trp478*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001032221.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP1 | ENST00000373302.8 | c.1434G>A | p.Trp478* | stop_gained | Exon 16 of 20 | 1 | NM_003165.6 | ENSP00000362399.3 | ||
STXBP1 | ENST00000373299.5 | c.1434G>A | p.Trp478* | stop_gained | Exon 16 of 19 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1424546Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 704610
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Truncating variants in STXBP1 are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with early-onset epileptic encephalopathy (PMID: 20876469). This sequence change creates a premature translational stop signal at codon 478 (p.Trp478*) of the STXBP1 gene. It is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at